These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 2885202)

  • 1. Haemodynamic, metabolic, and lymphocyte beta 2-adrenoceptor changes following chronic beta-adrenoceptor antagonism.
    Whyte K; Jones CR; Howie CA; Deighton N; Sumner DJ; Reid JL
    Eur J Clin Pharmacol; 1987; 32(3):237-43. PubMed ID: 2885202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of CGP 17/582, a selective beta-adrenoceptor antagonist, on the haemodynamic and hypokalaemic response to adrenaline.
    Whyte KF; De Vane PJ; Whitesmith R; Kelman A; Reid JL
    Br J Clin Pharmacol; 1989 May; 27(5):553-61. PubMed ID: 2569322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade.
    McDevitt DG; Brown HC; Carruthers SG; Shanks RG
    Clin Pharmacol Ther; 1977 May; 21(5):556-66. PubMed ID: 15753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effect of selective beta 1 and nonselective beta-adrenoceptor blockade on epinephrine and atropine response in normal humans.
    Gullestad L; Forfang K; Simonsen S
    J Cardiovasc Pharmacol; 1992 Dec; 20(6):976-81. PubMed ID: 1282602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic, electrocardiographic, and hemodynamic responses to increased circulating adrenaline: effects of selective and nonselective beta adrenoceptor blockade.
    Hansen O; Johansson BW; Nilsson-Ehle P
    Angiology; 1990 Mar; 41(3):175-88. PubMed ID: 1968731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
    van den Meiracker AH; Man in't Veld AJ; Boomsma F; Fischberg DJ; Molinoff PB; Schalekamp MA
    Circulation; 1989 Oct; 80(4):903-14. PubMed ID: 2571431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of hemodynamic, humoral and metabolic responses to beta 1- and beta 2-adrenergic stimulation in man using atenolol and propranolol.
    McLeod AA; Brown JE; Kuhn C; Kitchell BB; Sedor FA; Williams RS; Shand DG
    Circulation; 1983 May; 67(5):1076-84. PubMed ID: 6299612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential changes in lymphocyte beta 2-adrenoceptor density by beta-blocker administration: role of intrinsic sympathomimetic activity.
    Daul A; Wang XL; Borchard U; Bock KD; Brodde OE
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S93-6. PubMed ID: 2427860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of celiprolol, propranolol, oxprenolol, and atenolol on respiratory function in hypertensive patients with chronic obstructive lung disease.
    Fogari R; Zoppi A; Tettamanti F; Poletti L; Rizzardi G; Fiocchi G
    Cardiovasc Drugs Ther; 1990 Aug; 4(4):1145-9. PubMed ID: 1982059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-adrenoceptor blockade and hypoglycaemia. A randomised, double-blind, placebo controlled comparison of metoprolol CR, atenolol and propranolol LA in normal subjects.
    Kerr D; MacDonald IA; Heller SR; Tattersall RB
    Br J Clin Pharmacol; 1990 Jun; 29(6):685-93. PubMed ID: 1974143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of acute vs chronic treatment with beta-adrenoceptor blockade on exercise performance, haemodynamic and metabolic parameters in healthy men and women.
    Gullestad L; Hallen J; Medbø JI; Grønnerød O; Holme I; Sejersted OM
    Br J Clin Pharmacol; 1996 Jan; 41(1):57-67. PubMed ID: 8824694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of propranolol, alprenolol, pindolol, and bopindolol on beta 2-adrenoceptor density in human lymphocytes.
    Brodde OE; Wang XL; O'Hara N; Daul A; Schiess W
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S70-3. PubMed ID: 2439825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic beta-adrenoceptor antagonist treatment modulates human cardiac and vascular beta-adrenoceptor density in a subtype-selective fashion.
    Brodde OE; Michel MC; Wang XL; Zerkowski HR
    J Hypertens Suppl; 1988 Dec; 6(4):S497-500. PubMed ID: 2907348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of beta-adrenoceptor antagonist administration on beta 2-adrenoceptor density in human lymphocytes. The role of the "intrinsic sympathomimetic activity".
    Brodde OE; Daul A; Stuka N; O'Hara N; Borchard U
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):417-22. PubMed ID: 2859531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different changes of plasma membrane beta-adrenoceptors in rat heart after chronic administration of propranolol, atenolol and bevantolol.
    Horinouchi T; Morishima S; Tanaka T; Suzuki F; Tanaka Y; Koike K; Miwa S; Muramatsu I
    Life Sci; 2007 Jul; 81(5):399-404. PubMed ID: 17628611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
    Pringle TH; O'Connor PC; McNeill AJ; Finch MB; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1986 Mar; 21(3):249-58. PubMed ID: 2870732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the metabolic responses to inhaled salbutamol in the measurement of beta 2-adrenoceptor blockade.
    Lipworth BJ; McFarlane LC; Coutie WJ; McDevitt DG
    Eur J Clin Pharmacol; 1989; 37(3):297-300. PubMed ID: 2575521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisoprolol (EMD 33512), a highly selective beta 1-adrenoceptor antagonist: in vitro and in vivo studies.
    Brodde OE
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S29-35. PubMed ID: 2439795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of five beta-adrenoceptor blocking agents on sinoatrial conduction time in isolated blood-perfused canine atria.
    Shimotori M; Kobayashi M; Chiba S
    Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):240-52. PubMed ID: 2862847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioprotection by blockade of beta 2-adrenoceptors.
    Vincent HH; Man in 't Veld AJ; Boomsma F; Derkx FH; Wenting GJ; Schalekamp MA
    Eur Heart J; 1983 Jul; 4 Suppl D():109-15. PubMed ID: 6137369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.